44 results
D
ADAP
Adaptimmune Therapeutics Plc
2 Oct 14
$103.81M in equity / Series A Preferred Shares, sold $103.81M, 22 investors
12:00am
Utilities
Energy Conservation
Environmental Services
Oil & Gas
Other Energy
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians …
Pharmaceuticals
Other Health Care
Manufacturing
Real Estate
Commercial
Construction
REITS & Finance
Residential
Other Real Estate
Retailing
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
in the Company’s group health care coverage programs, your coverage ends on the last day of the month in which the Separation Date occurs (the “Health Care Coverage … End Date”). You will have the right to continue group health care coverage in those programs after the Separation Date under the law known
10-Q
9oqhvwr1id4
12 May 16
Quarterly report
12:00am
20-F
c7ixw 7l5izwoacm2s
13 Oct 15
Annual report (foreign)
12:00am